NEWSWEEK YALE Risch HCQ
As professor of epidemiology at Yale School of Public Health, I have authored over 300 peer-reviewed publications and currently hold senior positions on the editorial boards of several leading journals. I am usually accustomed to advocating for positions within the mainstream of medicine, so have been flummoxed to find that, in the midst of a crisis, I am fighting for a treatment that the data fully support but which, for reasons having nothing to do with a correct understanding of the science, has been pushed to the sidelines. As a result, tens of thousands of patients with COVID-19 are dying unnecessarily. Fortunately, the situation can be reversed easily and quickly.
I am referring, of course, to the medication hydroxychloroquine. When this inexpensive oral medication is given very early in the course of illness, before the virus has had time to multiply beyond control, it has shown to be highly effective, especially when given in combination with the antibiotics azithromycin or doxycycline and the nutritional supplement zinc.
https://pubmed.ncbi.nlm.nih.gov/32458969/
Early Outpatient Treatment (Hydroxychloroquine) of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis
National Center for Biotechnology Information
https://academic.oup.com/aje/article/doi/10.1093/aje/kwaa093/5847586
Early Outpatient Treatment(Hydroxychloroquine) of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis
American Journal of Epidemiology
https://watermark.silverchair.com/kwaa093.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAArMwggKvBgkqhkiG9w0BBwagggKgMIICnAIBADCCApUGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMBQrYc6-SV56XWIBSAgEQgIICZt5cAOqglwhuYvkTtnQwCf9iTgLTT26JyxNYvn1GsnLjR9pgNckdlxkW3FLBVGOn_mWvZz20ea9twrsH86rCPPrcBk7nxMIvnv5tlxqFGhpXMUgTR6CGv38gfDfUy3Le37tT3kPWpLjfyWZZu66U1kzHiag4-ypUI3IpEFFMOfJyN8oSS7Zdp615xDlV0HG5EVT5CCq4xYqPOdZDTIfImMs4anbFzj0JurfHrQJBOVoRLHO7lW6FYmynX1T6Fr-TQFCs5-FlTv5eY1y2s-oXhJ0AJ7D2hvCSEXzOlwTDZIAXEiuQAHmXCWonogJ7zO54RQXxf3Eip0_wJEeJtfHXFcTLSddbpwr8wOe_JuY1A4e1cmC4j6mqcbGOmEPnfwMhXBZiu3wNsnNAT2JJ2RVqisUPs9XJQysY9yBdtDTbVrNLuesjzOrm3mD-R-0NQjd73yi3HO9fvXgUi6ACwv7w8bQZURtZYUXPBwAHTvGgCrmqh22KTyd0nGUsgFjxfC7GtRHUHE4-QlfF4DWwF0QhroAvX3FT5WCK-6TCSDMgTbkk4Od3yocJ1hhTsO2z1w5BOCFl7eelLfzQwfAMhTHuck30D9uXqenAzPZ8C-UXW7RBbieQEv85rm6emcuSPQsv1pOXyZ5JQm4-enDOjAAsbJtp1bATBcotjFB6hJBe45bFcYCL1Ku-kFyq8ACOgqi7OQCCaUHzZ3ODI4tIdRSF-9kkMFkwq1SFcHZZVFsaFHg0e7ejIJsPZ_k84CN4uDQcGZfr9QQak0xuzYOW8UfQxDqBIWB1MkeGLANBjJp2Tji9R2AHCZcI